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Recovery from stroke engages mechanisms of
neural plasticity. Here we examine a role for MHC
class I (MHCI) H2-Kb and H2-Db, as well as PirB
receptor. Thesemolecules restrict synaptic plasticity
and motor learning in the healthy brain. Stroke
elevates neuronal expression not only of H2-Kb and
H2-Db, but also of PirB and downstream signaling.
KbDb knockout (KO) or PirB KO mice have smaller
infarcts and enhanced motor recovery. KO hippo-
campal organotypic slices, which lack an intact
peripheral immune response, have less cell death
after in vitro ischemia. In PirB KO mice, corticospinal
projections from the motor cortex are enhanced, and
the reactive astrocytic response is dampened after
MCAO. Thus, molecules that function in the immune
system act not only to limit synaptic plasticity in
healthy neurons, but also to exacerbate brain injury
after ischemia. These results suggest therapies for
stroke by targeting MHCI and PirB.INTRODUCTION
After stroke, the extent of brain and behavioral recovery is
influenced by local inflammatory changes and neural circuit
plasticity. Inflammation exacerbates damage through a range
of mechanisms, including activation of microglia, oxidative
stress, and infiltration by peripheral immune cells (Choe et al.,
2011; Hurn et al., 2007; Offner et al., 2006). Increased functional
recovery is associated with neural plasticity, including axonal
sprouting in corticospinal projections that occurs days to weeks
after ischemic injury (Carmichael et al., 2001; Lee et al., 2004;
Netz et al., 1997). Ischemia induces changes in neuronal excit-
ability and alters dendritic spines within hours (Brown et al.,
2007, 2008; Takatsuru et al., 2009). Sprouting and growth of
intracortical axons are also thought to serve as substrates for
recovery in the somatosensory and visual cortex after peripheral
injury or retinal lesion (Florence et al., 1998; Palagina et al., 2009;
reviewed in Benowitz and Carmichael, 2010) and can happen1100 Neuron 73, 1100–1107, March 22, 2012 ª2012 Elsevier Inc.rapidly (Yamahachi et al., 2009). On the other hand, cellular
correlates of synaptic plasticity, such as long-term potentiation
(LTP), are diminished by stroke (Sopala et al., 2000; Wang
et al., 2005). These observations suggest that recovery might
be enhanced not only by dampening inflammation, but also by
increasing synaptic and structural plasticity.
Recently, we discovered that mice lackingmajor histocompat-
ibility class I (MHCI) function have enhanced visual cortical
and hippocampal plasticity not only in development, but also in
adulthood (Corriveau et al., 1998; Datwani et al., 2009; Huh
et al., 2000; Shatz, 2009). MHCI molecules are expressed in
neurons and are located at synapses in the healthy central
nervous system (CNS) (Datwani et al., 2009; Needleman et al.,
2010), and knocking out (KO) just H2-Kb (Kb) and H2-Db (Db)
(KbDb KO), two of the more than 50 MHCI genes, is sufficient
to enhance plasticity in mouse visual cortex (Datwani et al.,
2009) and cerebellum (McConnell et al., 2009). An innate immune
receptor, PirB (paired immunoglobulin-like receptor B) is known
to bind MHCI both in neurons (Syken et al., 2006) and in the
immune system (Matsushita et al., 2011; Takai, 2005). Like Kb
and Db, PirB is expressed in forebrain neurons, and PirB KO
mice also have greater visual cortical plasticity (Syken et al.,
2006). MHCI molecules are upregulated by inflammation both
in the immune system and in the CNS after damage or viral infec-
tion (Piehl and Lidman, 2001; Thams et al., 2008). Because
these molecules play a dual role in the peripheral immune
response and in neural plasticity in the CNS, they could be
involved not only in the acute phases of stroke, but also in sub-
sequent recovery. After stroke, these molecules might make
a dual contribution to exacerbate damage in the context of the
inflammatory response and to restrict recovery by limiting
plasticity. Here, we investigate these possibilities by examining
response to in vivo and in vitro models of stroke in PirB KO
mice and KbDb KO mice.
RESULTS
KbDb KO Mice Recover Better than WT after Stroke
To examine whether Kb and Db contribute to damage after
stroke, we gave adult KbDb KO mice (Vugmeyster et al., 1998)
transient middle cerebral artery occlusion (MCAO; Han et al.,
2009). KbDb KO mice subjected to MCAO had no significant
difference from wild-type (WT) in infarct area at 24 hr postinjury
Figure 1. KbDb KO Mice Recover Better than WT Cohorts after
MCAO
(A) Top: example of sections of cresyl-violet-stained brains 7 days post-
MCAO. Bottom: KO animals have significantly smaller infarct areas at 7 days
(p = 0.03), but not 1 day (p = 0.45), post-MCAO. (B and C) KO animals
outperform WT cohorts on motor tasks post-MCAO. Average rotarod (B) and
foot fault (C) performances were assessed on days 2 and 7 post-MCAO in all
animals, and cohorts of each genotype were kept through 1 month survival,
with additional testing on days 14, 21, and 28. p values for the comparisons
between genotypes on rotarod on days 21 and 28 were 0.056 and 0.057,
respectively, reflecting the reduced numbers of surviving animals. Groups
were 19–25 mice (days 2 and 7) and 7–10 mice (days 14–28). *p < 0.05. Data
are represented as mean ± SEM. See also Figure S1.
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Improved Recovery from MCAO in MHCI or PirB KO(37% versus 41%; p = 0.45; Figure 1A), and their initial neurolog-
ical deficit was also similar (p = 0.4; see Figure S1A available
online; Han et al., 2009). However, by 7 days post-MCAO, infarct
area in KbDb KO mice was modestly reduced (32%) compared
to WT (44%; p = 0.03). Physiological parameters monitored
during surgery were similar between WT and KO and fell within
previously reported ranges (Table S1; Han et al., 2009).
To examine motor recovery after MCAO, we tested KbDb
KO and WT mice on two motor performance tasks, rotarod
and foot fault. Prior to MCAO, KO and WT mice learned
both tasks, improving performance over subsequent trials, as
evidenced by the increased latency to fall from the rotarod
(Figure S1B) and fewer missteps on foot fault (Figure S1C). KO
mice learned both behaviors better than WT (p < 0.001), con-
sistent with prior observations of enhanced motor learning
(McConnell et al., 2009). After stroke, performance on rotarod
and foot fault was significantly better in KO mice versus WT
(p < 0.001 for both paradigms; Figures 1B and 1C). Overall,
KbDb KO mice had smaller infarcts and recovered significantly
faster and to a greater extent on motor performance (to 91%
of prestroke rotarod time compared to 75% for WT at 28 days).
Kb and Db Expression Increase after MCAO
The observations that KbDb KO mice have smaller infarct
areas and better behavioral recovery after MCAO suggest that
Kb and Db may contribute to damage in WT mice. Moreover,
because mice lacking Kb and Db have enhanced synaptic
plasticity, it is conceivable that increased expression wouldcontribute to diminished plasticity, thereby compromising
recovery. To examine this idea further, we assessed MHCI
levels after MCAO. Quantitative real-time PCR (qRT-PCR) re-
vealed highly increased Kb and Db mRNA in the damaged
hemisphere (ipsi) compared to sham control after MCAO (Fig-
ure 2A) both at 24 hr (Kb mRNA: 2.5-fold increase, p < 0.05;
Db mRNA: 3.1-fold increase, p < 0.001) and at 7 days
(Kb mRNA: 8.0-fold increase, p < 0.01; Db mRNA: 7.0-fold
increase, p < 0.001). Kb and Db levels in the damaged hemi-
spherewere also over 2-fold higher than levels in the undamaged
hemisphere at 24 hr post-MCAO and over 5-fold higher 7 days
post-MCAO (Figure 1A; p < 0.01). Western blot analysis of
Kb expression in both synaptosome-enriched samples or
synaptoneurosomes demonstrated increased protein levels
after MCAO in the damaged hemisphere relative to the undam-
aged side or sham (Figures 2B and 2C).
Because synaptoneurosomes enrich for synaptic proteins
(Johnson et al., 1997) after MCAO, Kb protein could be upregu-
lated at synapses and also possibly within glial processes that
enwrap the synapse. Previous studies have shown that MHCI
proteins are expressed in neurons and are closely associated
with synaptic markers in the healthy brain (Datwani et al., 2009;
Goddard et al., 2007). MHCI immunostaining, using an antibody
known to recognize both Kb and Db (McConnell et al., 2009;
Needleman et al., 2010), is primarily associated with neurons
in brain sections taken from the cortical penumbra 7 days
post-MCAO or from the unmanipulated cortex, as assessed by
colocalization with the neuronal marker neuron-specific enolase
(NSE). Staining is not detected in astrocytes or microglia (Figures
2D and 2E; Figure S2). As expected, there is evidence of both
astrocytic and microglial activation post-MCAO (Figure 2E).
Together, these observations demonstrate that Kb and Db are
upregulated after MCAO and that within the cortical penumbra,
this upregulation is associatedwith increased protein expression
in neurons and at or near synapses.
Improved Outcomes in Mice Lacking PirB Receptor
To explore further how absence of Kb and Db in the brain might
lead to neuroprotection, we next examined mice lacking the
MHCI receptor PirB (Shatz, 2009; Syken et al., 2006; Takai,
2005). PirB is expressed in CNS neurons, including pyramidal
cells, throughout the cerebral cortex. Seven days post-MCAO,
PirB KO mice had smaller infarcts than WT (KO: 18% versus
WT: 35%; p = 0.0001), even though infarct area was the same
at 24 hr post-MCAO (Figure 3A). Between 1 to 7 days post-
MCAO, infarct area in PirB KO mice decreased significantly
(by 51%), as assessed by cresyl violet staining. Because cresyl
violet stains acidic cellular components, particularly polyribo-
somes (Tu¨reyen et al., 2004), the decrease in infarct area in KO
mice may reflect recovery of protein synthesis in stressed cells
within the penumbra. In KbDb KO mice at 7 days post-MCAO,
infarct area is also reduced compared to WT (KbDb KO: 32%
versus WT: 44%; p = 0.03) but to a lesser degree than in PirB
KO. Together, these data suggest that knockout of PirB has
a similar or even greater effect on infarct size than when Kb
and Db are deleted.
To determine whether protection in PirB KOmice is also asso-
ciated with improved motor performance, we assessed animalsNeuron 73, 1100–1107, March 22, 2012 ª2012 Elsevier Inc. 1101
Figure 2. Expression of Kb and Db
Increases in Brain of WT Mice after MCAO
(A) Kb and Db gene expression was measured
using qPCR at 24 hr (n = 7 for each experimental
condition) or 7 days (n = 7, MCAO; n = 4–8, sham)
post-MCAO (ipsi, damaged hemisphere; contra,
undamaged hemisphere). Negative control data
from KbDb KO samples demonstrate primer
specificity (Kb:GAPDH = 0.06 control relative to
sham; Db:GAPDH = 0.01 control relative to sham;
p < 108 for both). *p% 0.05; **p% 0.01. (B and C)
Western blots showing protein expression of Kb
7 days post-MCAO in synaptosome-enriched
preparations (B) and in synaptoneurosomes (C). C,
contralateral to injury; I, ipsilateral to injury; M1–4,
different MCAO animals; S1–4, shams; KO, KbDb
KO. (D and E) Immunohistochemistry of L5 in
cortical penumbra using OX18 antibody. (D)
Majority of MHCI immunostaining (OX18, red) co-
localizes with neuronal marker NSE (green) 7 days
post-MCAO. (E) GFAP (astrocytes, green) or Iba1
(microglia, green) 7 days post-MCAO. Scale bars
in (D) and (E) represent 50 mm. qPCR data are
represented as mean ± SEM. See also Figure S2.
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and remained on the rod longer than WT over the course of
the pretraining period (p < 0.0001; Figure S1E; no genotype
differences were observed with training on the foot fault task,
p = 0.45; Figure S1F). After MCAO, PirB KO mice performed
better than WT on rotarod (p = 0.001) and foot fault (p = 0.02)
by 7 days post treatment; even at 2 days post-MCAO, KO
mice performed better than WT on foot fault (p = 0.01; Figures
3B and 3C). Together, these observations in PirB KO mice are
strikingly similar to those for KbDb KO mice, suggesting that
knocking out a receptor for these two MHCI molecules results
in strong neuroprotection most apparent 7 days post-MCAO.
Astrocyte Activation Is Reduced after MCAO
in PirB KO Mice
Experimentally and clinically, stroke is followed by an inflamma-
tory response characterized by production of inflammatory
cytokines, infiltration of leukocytes and monocytes, and activa-
tion of resident glial cells (Choe et al., 2011; Offner et al., 2006;
Nedergaard and Dirnagl, 2005). Although activated astrocytes
and microglia can exert beneficial effects, inflammation can
also compromise neuronal survival and worsen ischemic
damage. To determine whether PirB deletion alters glial activa-
tion 7 days post-MCAO, we immunolabeled brain sections for
astrocyte and microglia and/or macrophage markers, and the
number of activated cells in the cortical penumbra (Figure 3D)
were counted. The number of reactive astrocytes decreased in
PirB KO versus WT (GFAP+: 26% decrease, p = 0.001; Figures
3E and 3F; Vimentin+: 32% decrease, p = 0.03; Figures S3A
and S3C). In contrast, the number of microglia did not differ
from WT (Figures S3B and S3D). Thus, the neuroprotection
afforded by PirB deletion appears to be accompanied by dimin-1102 Neuron 73, 1100–1107, March 22, 2012 ª2012 Elsevier Inc.ished numbers of activated astrocytes, but not microglia, in the
penumbra area. A decrease in Vimentin+ and GFAP+ reactive
astrocytes has been associated with better regenerative
capacity after spinal cord or traumatic brain injury (Menet
et al., 2003; Wilhelmsson et al., 2004). The diminished astrocytic,
but not microglial, activation might reflect the contribution of
astrocytes to synaptic plasticity and their close association to
synapses (Beattie et al., 2002; reviewed in Giaume et al.,
2010), where PirB and MHCI are thought to be located (Needle-
man et al., 2010; Shatz, 2009). Together, these observations
suggest that the astrocytic response after MCAO relies in part
on PirB signaling.
PirB Expression and Immediate Downstream Signaling
Are Increased after MCAO
Because outcome is improved in PirB KO mice, we assessed
whether PirB is upregulated inWTmice after MCAO. PirB protein
levels are markedly increased in the damaged hemisphere
post-MCAO, compared to the undamaged contralateral side or
to sham controls (Figure 3G). Western blot analysis (input) veri-
fied the increase in Kb protein level in the damaged hemisphere
(Figure 3H), similar to that observed in synaptosomes (Figure 2).
In the damaged hemisphere, there is also a significant increase
in b2m (Figure 3H). Because b2m is necessary for stable cell
surface expression of the majority of MHCI proteins (Huh et al.,
2000), it is likely that the increase in levels of Kb and Db is ac-
companied by increased cell-surface expression after MCAO.
MHCI binding to PirB facilitates tyrosine phosphorylation of
PirB on cytoplasmic immunoreceptor tyrosine-based inhibitory
motifs, which in turn recruits SHP-1 and SHP-2 phosphatases
to PirB and modulates downstream signal transduction
pathways (Nakamura et al., 2004; Takai, 2005). Therefore, we
Figure 3. PirB KO Enhances Recovery and
Dampens Astrocytic Response; MCAO
Increases PirB Proximal Signaling
(A) KO animals have smaller infarct areas 7 days
post-MCAO (n = 10 per genotype), but not 24 hr
post-MCAO (n = 7 for WT; n = 8 for KO). Infarct
area decreased 51% in KO mice at 7 days versus
1 day post-MCAO (p = 0.003). (B and C) KO
animals outperform WT cohorts on motor tasks
after MCAO. Average rotarod (B) and foot fault (C)
performances at 2 days and 7 days post-MCAO.
n = 10–20 animals per condition. Rotarod perfor-
mance of PirB WT was not significantly different at
7 days compared to 2 days post-MCAO; p = 0.61.
Data are represented as mean ± SEM. (D–F)
Astroglial activation is diminished in cortical
penumbra 7 days post-MCAO in PirB KOmice. (D)
Cresyl-violet-stained section; rectangle indicates
cortical area used for cell counting. (E) Repre-
sentative images of astrocytes immunostained for
GFAP at a distance of 400 mm from the ischemic
core. (F) Quantitation of GFAP+ cells in WT versus
KO. *p < 0.05, n = 5 animals per experimental
condition. Scale bars represent 50 mm. (G–J)
Enhanced PirB expression and PirB proximal
signaling after MCAO. (G) Protein extracts from
7 days post-MCAO (M) or sham (S) brains were
immunoprecipitated with anti-PirB antibody,
followed by western blotting for PirB. In each
experiment (n = 2), four hemispheres from sham
(S1–4; S5–8) or MCAO (M1–4; M5–8) brains were pooled for protein extraction. C, contralateral to injury; I, ipsilateral to injury. (H) Expression of Kb, b2m, and
b-tubulin in brain lysates from (G). (I and J) Aliquots of protein extracts from (G) were subjected to immunoprecipitation for phosphotyrosine (I) or SHP-2 (J) to
assess levels of tyrosine phosphorylation of PirB and SHP-2 recruitment to PirB. See also Figures S1 and S3.
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MCAO is associated with known PirB signaling components in
the brain (Syken et al., 2006). Both PirB phosphorylation and
SHP-2 recruitment to PirB increase significantly after MCAO
(Figures 3I and 3J). Thus, a notable consequence of MCAO
is to engage the first key steps in PirB downstream signal
transduction.
Diminished Cell Death in PirB and KbDb KO
in an In Vitro Model of Ischemia
PirB and KbDb KO mice have smaller infarcts and better motor
recovery, suggesting that thesemolecules exert their deleterious
effects in WT both by causing more cell death within the infarct
and by limiting compensation via synaptic plasticity in surviving
circuits. Because Kb, Db, and PirB also function in the immune
system, the smaller infarcts seen in KO mice might arise from
a dysregulated immune response (Maenaka and Jones, 1999;
Takai, 2005), rather than from absence of expression in the
CNS. To examine this possibility, we employed an in vitro model
of ischemia: 15 min of oxygen glucose deprivation (OGD) of
hippocampal organotypic slice cultures. The slices contain
resident astrocytes and microglia but few if any peripheral
immune cells. Circulating neutrophils, which might be present
initially within these slices, have life spans of only 8–20 hr, and
so are gone prior to experiments, which start after 2 weeks
in vitro; no new peripheral immune cells can infiltrate in response
to injury. The extent of neuronal cell death was assessed directly
in CA1 by using propidium iodide (PI) immunofluorescence 24 hrafter OGD insult (Ouyang et al., 2007; Figure 4A). Despite the
absence of peripheral immune system infiltration, cultures from
KbDb WT mice sustained significant damage, whereas cell
death was significantly reduced in cultures from KbDb KO
mice, as indicated by a 55% decrease in average PI fluores-
cence intensity (KbDb KO: 38 ± 1.9 median pixel intensity versus
WT: 89 ± 3.4; p < 0.0001; Figure 4A). Cultures from PirB KOmice
also had less cell death than WT, visualized as a 54% decrease
in average PI fluorescence intensity compared to WT (PirB
KO: 64 ± 3.7 median pixel intensity versus WT: 141 ± 7.3; p <
0.0001; Figure 4B). These observations demonstrate that
in vitro as well as in vivo, PirB, Kb, and Db contribute to damage
after ischemia. In addition, results suggest that, in vivo, the
absence of these molecules in brain cells (neurons and/or
resident glia), rather than just in the peripheral immune system,
is neuroprotective.
Increased Crossed Projections of CST Axons
after MCAO in PirB KO Mice
Functional recovery after stroke is associated with axonal
plasticity as well as with altered gene expression profiles (Lee
et al., 2004; Li et al., 2010; Netz et al., 1997; Stinear et al.,
2007; reviewed in Benowitz and Carmichael, 2010). Cortical
injury increases axonal projections descending from layer 5
(L5) pyramidal neurons in undamaged motor cortex that cross
to innervate denervated subcortical targets, including red
nucleus and spinal cord (Lee et al., 2004; Naus et al., 1985; Rouil-
ler et al., 1991). L5 pyramidal neurons express PirB, and proteinNeuron 73, 1100–1107, March 22, 2012 ª2012 Elsevier Inc. 1103
Figure 4. Diminished Neuronal Death in CA1 Region of Hippocampal
Organotypic Slice Cultures from KO Mice after In Vitro Ischemia
PI-immunofluorescence (bright white) in CA1 region (top) and cumulative
histograms of neuronal damage, as measured by fluorescence intensity at
24 hr after OGD (bottom), show that deletion of Kb and Db (A) or PirB (B)
reduces cell death compared to WT. For cumulative histograms, each point is
one slice (KbDb KO: n = 55 versusWT: n = 52 slices from five animals; PirB KO:
n = 27 versus WT: n = 30 slices from four animals). Arrows indicate measured
CA1 area. Scale bars represent 800 mm.
Figure 5. Increased Corticospinal Tract Fibers in PirB KO versusWT
Mice 28 Days Post-MCAO
(A) Representative images of BDA-labeled crossed CST fibers originating in
undamaged motor cortex and terminating in the red nucleus on the damaged
side. (Midline is to the right of each image.) Notemore extensive labeling in KO.
(B) The uncrossed CST projection to the red nucleus terminating on the
undamaged side. (Midline is to the left of each image.) Note similarity of
labeling in KO versus WT. (C–E) Quantification of crossed fibers from
undamaged CST by total fiber length (C) (WT = 6.5 ± 6.0 mm; KO = 9.9 ±
1.3 mm; p = 0.032), fiber number (D) (WT = 81.9 ± 9.7; KO = 118.1 ± 11.1; p =
0.036), or number of fibers crossing the midline (E) (WT = 7.9 ± 1.0; KO = 11.2 ±
0.6; p = 0.024). n = 5, KO; n = 6, WT; two to three sections per animal were
analyzed. Scale bars represent 100 mm. Data are represented as mean ± SEM.
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development, as well as in cortical neuron growth cones
in vitro (Syken et al., 2006). Deletion of PirB increases axon
outgrowth on myelin inhibitory substrates in vitro (Atwal et al.,
2008). Consequently, it is possible that enhanced recovery
from MCAO in PirB KO mice arises in part from an enhanced
capacity of L5 pyramidal axons descending from the intact
hemisphere to cross the midline into denervated territory.
To determine whether there are a greater number of crossed
corticospinal tract (CST) fibers, we injected the anterograde
tracer BDA into contralateral (undamaged hemisphere) motor
cortex 14 days post-MCAO in PirB KO and WT to label the
descending axons from L5 pyramidal neurons in the intact
hemisphere. BDA-positive fibers were examined in the red
nucleus ipsilateral (Figure 5A) or contralateral (Figure 5B) to
the injury. In the ipsilateral red nucleus of PirB KO mice, there
was an increase in all measured parameters of crossed axons:
fiber length (Figure 5C; 52.3% increase in KO; p = 0.032), fiber
number (Figure 5D; 44.2% increase in KO; p = 0.036), and the
number of fibers crossing the midline (Figure 5E; 41.8%
increase in KO; p = 0.024) were greater than in lesioned WT
controls. To exclude the possibility that the increase in BDA-
positive fibers was due to better labeling in KO than in WT
mice, we calculated the mean pixel intensity of BDA labeling
in contralateral red nucleus. No difference was seen between
KO and WT (WT = 181.4 ± 3.1; KO = 175.8 ± 4.1; p = 0.30).
The increase in labeled fibers in PirB KO mice is also unlikely
to be due to a difference in infarct size, because average infarct
index between WT and KO was not different at the conclusion of
the tract-tracing experiment (WT index = 14.5 ± 6.6; KO index =
12.4 ± 5.3; p = 0.813). The increase in crossed CST fibers from
the intact motor cortex that terminated within the denervated
red nucleus in PirB KO mice could account for their improved1104 Neuron 73, 1100–1107, March 22, 2012 ª2012 Elsevier Inc.behavioral outcome post-MCAO and suggests that L5 pyra-
midal neurons in these mice have greater axonal plasticity in
response to stroke.DISCUSSION
Here we show significant neuroprotection in the absence of
either the innate immune receptor PirB or two of its MHCI ligands
Kb and Db by using in vivo and in vitro ischemia models. Motor
performance in KO mice recovered to a greater degree than in
WT, and infarct area was smaller in KO but only after 7 days
and not 24 hr post-MCAO. This delay is consistent with the
idea that mechanisms of synaptic plasticity and functional
recovery take time and may be more fully engaged in KO mice.
qRT-PCR and western blotting revealed dramatically
increased expression levels of Kb and Db in the damaged hemi-
sphere of WT mice. b2m protein, the light chain that is coex-
pressed with MHCI molecules (Zijlstra et al., 1990), is also
elevated after MCAO, implying that there is an increase in stable
cell-surface expression of MHCI protein. Because PirB expres-
sion, phosphorylation, and its interaction with SHP-2 are also
increased, these observations argue mechanistically for an
increase in signaling cascades downstream of the PirB receptor.
Together, these experiments identify a set of molecules that,
when present, exacerbate damage caused by stroke and,
when removed, permit more extensive recovery.
The greater recovery in PirB versus KbDb KO mice fits well
with a model in which PirB binds not only Kb and Db, but also
other ligands. In addition to classical MHCIs, PirB is also thought
to bind Nogo (Atwal et al., 2008) and to collaborate with the
Neuron
Improved Recovery from MCAO in MHCI or PirB KONogo receptor (NgR), which itself cannot signal (Fournier et al.,
2002). Mice lacking Nogo or NgR, like PirB mice, have enhanced
synaptic plasticity (McGee et al., 2005), and blocking NgR
function also enhances recovery after MCAO (Lee et al., 2004).
Thus, deletion of PirB would be expected to have a larger effect
than deleting only a subset of ligands. It will be worthwhile to
explore PirB interaction with other ligands as well as receptors
in the context of neuroprotection from stroke. An important
implication of the findings reported here is that new avenues of
therapy after stroke may be available, because PirB in humans
has only a limited number of homologs, members of the LILRB
family (Takai, 2005). As a key step, it will be necessary to explore
whether acute blockade of PirB or LILRBs can also lead to
neuroprotection.
Increased CST Projection in PirB KO Can Account
for Enhanced Functional Recovery
After stroke, neurons in undamaged cortical regions extend
their axons into damaged regions and become responsive to
motor or sensory functions perturbed by injury (Lee et al.,
2004; Netz et al., 1997). In PirB KO mice, an increased number
of midline crossing fibers from the undamaged corticospinal
tract were seen extending into the denervated red nucleus
28 days post-MCAO. These observations support previous
studies showing that PirB and MHCI ligands limit axonal
outgrowth in development and regeneration after injury in vitro
and in vivo (Atwal et al., 2008; Fujita et al., 2011; Washburn
et al., 2011; Wu et al., 2011). In vivo, PirB downstream signaling
inhibits Trk receptors that function to promote axonal outgrowth;
KO of PirB increases TrkB signaling and neurite outgrowth after
optic nerve injury (Fujita et al., 2011). However, our results
contrast with recent studies that report no difference in PirB
KO CST axonal projections using a traumatic brain or spinal
cord injury model (Nakamura et al., 2011; Omoto et al., 2010).
Note that these studies used entirely different injury paradigms
as well as a different PirB KO mouse. Our study suggests that
the increased number and length of CST fibers from the undam-
aged motor cortex that extend into the denervated red nucleus
can serve as a structural substrate for the improved recovery
observed in PirB KO mice after MCAO.
Is Protection Due to Changes in Immune Response,
in Neural Plasticity, or in Both?
In the healthy brain, neurons express both MHCI and PirB, with
MHCI protein detected at synapses (Datwani et al., 2009;
Needleman et al., 2010; Figure 2). Genetic deletion of either Kb
and Db or PirB results in enhanced synaptic plasticity in the
visual cortex, hippocampus, and cerebellum in development
and in adulthood (Datwani et al., 2009; Huh et al., 2000; McCon-
nell et al., 2009; Syken et al., 2006), consistent with the proposal
that MHCI and PirB receptor signaling limit synaptic plasticity
in the healthy brain (Shatz, 2009). Thus, the significant elevation
of MHCI and PirB expression, as well as PirB proximal signal-
ing components after MCAO (Figures 2 and 3), could reduce
synaptic plasticity of surviving neurons and circuits, thereby
limiting functional recovery. Indeed, cellular correlates of
synaptic plasticity, such as LTP, are blunted or absent after
MCAO (Sopala et al., 2000; Wang et al., 2005). After MCAO,neurons are the chief cell type in the brain in which MHCI ex-
pression is upregulated, as identified by colocalization of the
neuronal marker NSE with the OX18 antibody, which is known
to recognizeMHCIs in neurons and at synapses in rat andmouse
(Datwani et al., 2009; Needleman et al., 2010; Neumann et al.,
1995; Figure 2). An increase in Kb protein in synaptosomal
preparations was also observed, consistent with the possibility
that synaptic plasticity may be diminished after MCAO in WT
mice. These biochemical preparations not only include pre-
and postsynaptic membranes, but could also contain glial
processes that enwrap synapses, so it is possible that upregula-
tion also reflects a glial contribution. However, electron micros-
copy studies of MHCI protein in healthy brain sections show
localization primarily at synaptic and subsynaptic neuronal
membranes (Needleman et al., 2010), implying that neuronal
MHCI can be upregulated.
MHCIs and PirB are also normally expressed in the peripheral
immune system (Takai, 2005). KbDb KO mice have compro-
mised adaptive immune systems due to dampened CD8 T cell
responses (Schott et al., 2002). In contrast, PirB KO mice have
intact, even hyperactive, adaptive immune systems (Nakamura
et al., 2004). These diametrically opposed peripheral immune re-
sponses are not easily reconciled with the observations here that
ablation of either PirB orMHCI leads to neuroprotection. The fact
that these molecules are expressed and signal in neurons
suggests that neuroprotection is at least in part brain specific.
This conclusion is consistent with the OGD experiments using
hippocampal slice cultures, prepared from the healthy brain,
which lack functioning vasculature and in which peripheral
immune cells cannot participate. Neurons in this model are
thought to die as a consequence of apoptosis and necrosis
(Meloni et al., 2011). The KO slice cultures suffered less neuronal
cell death than WT cultures subjected to the same duration of
OGD, consistent with the idea that the function of these mole-
cules in the brain—in neurons or possibly other resident glial or
microglia—normally contributes to damage after stroke. Future
experiments involving cell-type-specific knockout mice will
help dissect the relative contribution of peripheral immune cells,
neurons, and brain glia to damage and impaired recovery.EXPERIMENTAL PROCEDURES
Animals
KbDb KO mice, offspring of breeding pairs on a C57BL/6 background, were
generously provided by H. Ploegh (Vugmeyster et al., 1998; Ziskin et al.,
2007). C57BL/6 (i.e., KbDb WT) controls were purchased (Charles River).
PirB KO and PirBWT controls were previously generated in C.J.S.’s laboratory
(Syken et al., 2006). Mice were maintained in a pathogen-free environment.
All experiments using animals were performed blind to genotype and in
accordance with a protocol approved by the Stanford University Animal
Care andUse Committee and in keeping with the National Institutes of Health’s
Guide for the Care and Use of Laboratory Animals.
Focal Cerebral Ischemia
Transient ischemia was induced in male mice (postnatal days 60–90) by using
the suture occlusion technique, as previously described (Han et al., 2009), with
slight modifications. This age was chosen because it is beyond the develop-
mental critical periods, but the animals are still relatively young adults.
See Supplemental Experimental Procedures for complete details of exper-
imental procedures.Neuron 73, 1100–1107, March 22, 2012 ª2012 Elsevier Inc. 1105
Neuron
Improved Recovery from MCAO in MHCI or PirB KOSUPPLEMENTAL INFORMATION
Supplemental Information includes three figures, one table, and Supplemental
Experimental Procedures and can be found with this article online at doi:10.
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